Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Nov 15, 2024
Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand
Learn More
May 13, 2022
Walvax announces the receipt of the purchase order from Morocco for the 13-valent pneumococcal polysaccharide conjugate vaccine
Learn More
Sep 18, 2024
Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI
Learn More